Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1,501
-
Total 13F shares, excl. options
-
1,004,542,606
-
Shares change
-
+27,281,464
-
Total reported value, excl. options
-
$81,371,526,834
-
Value change
-
+$2,310,126,305
-
Put/Call ratio
-
140%
-
Number of buys
-
704
-
Number of sells
-
-733
-
Price
-
$81.02
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2017
1,715 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2017.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,501 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,004,542,606 shares
of 1,240,722,841 outstanding shares and own 81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (102,244,888 shares), VANGUARD GROUP INC (94,527,796 shares), STATE STREET CORP (55,413,217 shares), Bank of New York Mellon Corp (30,096,665 shares), FMR LLC (27,711,666 shares), Capital Research Global Investors (21,868,631 shares), PARNASSUS INVESTMENTS /CA (18,695,139 shares), PRICE T ROWE ASSOCIATES INC /MD/ (18,564,001 shares), Invesco Ltd. (17,811,537 shares), and NORTHERN TRUST CORP (17,037,743 shares).
This table shows the top 1,501 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.